我在那里看病人 (1)
我的评论
选择研究
-
A 研究 to assess the efficacy of enasidenib and risk-adapted addition of azacitidine in newly diagnosed IDH2-mutant AML.
血液的进步
-
Venetoclax and Cobimetinib in Relapsed/Refractory AML: A Phase 1b Trial.
临床淋巴瘤、骨髓瘤 & 白血病
-
一切都取决于时机.
The New England journal of medicine
临床试验
Identifying Best Approach in Improving Quality of Life and Survival After a Donor Stem Cell Tra...
The arm with the largest mean change in Functional Assessment of Cancer Therapy-Bone Marrow Transplant (FACT-BMT) from baseline to day 90. The Wilcoxon rank-sum test will be used to compare change in FACT-BMT between arms, and thi...
招聘
4.9